CVR Medical released an update on the state of carotid stenotic scan clinical trial at the Jefferson Clinical Research Institute.
CVR Medical (TSXV:CVM) released an update on the state of carotid stenotic scan clinical trial at the Jefferson Clinical Research Institute.
As quoted in the press release:
“Enrollment was initiated in early January,” says Dr. Whellan. “The prototype device, which is being operated in standard form, will soon be joined by its wireless charging technology, for which preparation has gone smoothly. The CSS, as a whole, has been widely praised for its ease of use. The training required was straightforward and allowed the coordinators to quickly gain experience and implement the study. Since its successful implementation, we have had steadily growing enrollment. We’re looking forward to continuing our work with CVR.”
CVR CEO Peter Bakema states, “We are pleased with the progress of the ongoing clinical trials, for which enrollment has exceeded our expectation thus far. We are also happy to share the expected inclusion of the wireless charging device going forward. The simplicity and freedom it provides will serve to further enhance the application of the CSS. We are excited for the continuation of our work with Thomas Jefferson University, where implementation of four additional wired CSS devices will be immediately placed across the Thomas Jefferson University footprint, with multiple wireless devices close behind.”